The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Voluntary Field Corrective Action Issued for GE Healthcare's Avance, Aisys and Avance CS2 Anesthesia Delivery Systems

Tuesday, October 15, 2013

Voluntary Field Corrective Action Issued for GE Healthcare's Avance, Aisys and Avance CS2 Anesthesia Delivery Systems

16:22 EDT Tuesday, October 15, 2013

MADISON, Wis. (Business Wire) -- GE Healthcare has initiated a voluntary field corrective action for the Avance, Aisys and Avance CS2 anesthesia delivery systems with 8.00 (Avance and Aisys) or 10.00 (Avance CS2) software due to a potential safety issue. The affected units were manufactured from February 2011 through July 2013.

Clinicians may continue to use their Avance, Aisys and Avance CS2 anesthesia delivery system, but should be aware that a unique sequence of inputs and a collapsed bellow could result in delivery of higher-than-expected tidal volume when using the Pressure Control Ventilation – Volume Guarantee (PCV-VG) mode. All safety over-pressure controls and alarms will continue to function properly. However, over delivery of tidal volume may result in alterations to blood flow within the thorax that, under extreme circumstances, may result in gradual reductions in blood pressure. The unique sequence of inputs includes transitioning from mechanical PCV-VG mode to manual ventilation, changing the set tidal volume (while in manual mode), and then returning to mechanical PCV-VG mode. To avoid this situation, when using PCV-VG mode, do not adjust the ventilator tidal volume while in a manual ventilation mode. At any time during the use of the device should an over delivery of tidal volume occur while in PCV-VG mode, transitioning to a different ventilation mode will resolve the issue.

GE Healthcare has begun notifying customers with affected units through an Urgent Medical Device Correction letter, which alerts users of the concern and provides instructions to mitigate the issue. GE Healthcare is following up with all customers and will correct all affected systems at no cost to customers. To date, no patient injuries have been reported with regards to this issue.

For additional information regarding this field action, please contact GE Healthcare's Customer Service line (24 hours a day, 7 days a week) at 1-800-345-2700.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA:

  • Online at (form available to fax or email), or
  • Call FDA 1-800-FDA-1088.

Press Contact
GE Healthcare
Annette Busateri, +1-262-442-0966

  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Secure Service
Customer Service
Advertising Privacy
Globe Recognition
Mobile Apps
Other Sections